Levetiracetam and cutaneous adverse reactions: a systematic review of descriptive studies

ConclusionClinicians should be aware of the possible CADRs induced by LEV to avoid fatal condition. Immediate withdrawal of the drug and supporting care seem to be effective in the management of the CADRs.Registration Number: International Prospective Register for Systematic Reviews (PROSPERO) number CRD42019141002.
Source: Seizure - Category: Neurology Source Type: research